secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cibus, Inc. (CBUS)
CIK:        0001705843
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001193125-26-027229
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud

Cibus Updates Business Outlook in 8-K, Projects >$200M Annual Royalties from Rice Traits
--------------------------------------------------------------------------------

- Cibus estimates over $200 million potential annual addressable royalties from Rice herbicide tolerance traits in the US and Latin America.
- Company reduced workforce by approximately 34 full-time employees by December 31, 2025, to streamline focus on Rice program.
- Anticipates annual net cash usage of $30 million or less during 2026 following cost reduction actions.
- Biofragrance products program could reach $20-40 million annual revenue over a long-term horizon, with initial payments received in 2025.
- EU trilogue on New Genomic Techniques positively concluded in December 2025, creating a regulatory path for gene-edited plants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1705843/000119312526027229/0001193125-26-027229-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1705843/000119312526027229/d210187d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-027229

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer